322 related articles for article (PubMed ID: 34724274)
1. Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer.
Kooshki L; Mahdavi P; Fakhri S; Akkol EK; Khan H
Biofactors; 2022 Mar; 48(2):359-383. PubMed ID: 34724274
[TBL] [Abstract][Full Text] [Related]
2. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.
Kooshki L; Zarneshan SN; Fakhri S; Moradi SZ; Echeverria J
Phytomedicine; 2023 Apr; 112():154686. PubMed ID: 36804755
[TBL] [Abstract][Full Text] [Related]
3. Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration.
Fakhri S; Iranpanah A; Gravandi MM; Moradi SZ; Ranjbari M; Majnooni MB; Echeverría J; Qi Y; Wang M; Liao P; Farzaei MH; Xiao J
Phytomedicine; 2021 Oct; 91():153664. PubMed ID: 34391082
[TBL] [Abstract][Full Text] [Related]
4. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.
Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931
[TBL] [Abstract][Full Text] [Related]
5. The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism.
Fakhri S; Khodamorady M; Naseri M; Farzaei MH; Khan H
Pharmacol Res; 2020 Sep; 159():104895. PubMed ID: 32422342
[TBL] [Abstract][Full Text] [Related]
6. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
8. Lactate in the tumour microenvironment: From immune modulation to therapy.
Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
[TBL] [Abstract][Full Text] [Related]
9. A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.
Naeem M; Iqbal MO; Khan H; Ahmed MM; Farooq M; Aadil MM; Jamaludin MI; Hazafa A; Tsai WC
Molecules; 2022 May; 27(11):. PubMed ID: 35684353
[TBL] [Abstract][Full Text] [Related]
10. Targeting glycolysis for cancer therapy using drug delivery systems.
Huang Y
J Control Release; 2023 Jan; 353():650-662. PubMed ID: 36493949
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Glycolysis in Head and Neck Cancer.
Raj S; Kumar A; Kumar D
Adv Exp Med Biol; 2021; 1280():219-230. PubMed ID: 33791985
[TBL] [Abstract][Full Text] [Related]
12. The Immune Consequences of Lactate in the Tumor Microenvironment.
Harmon C; O'Farrelly C; Robinson MW
Adv Exp Med Biol; 2020; 1259():113-124. PubMed ID: 32578174
[TBL] [Abstract][Full Text] [Related]
13. Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy.
Cheng Q; Shi XL; Li QL; Wang L; Wang Z
Adv Sci (Weinh); 2024 Jan; 11(3):e2305662. PubMed ID: 37941489
[TBL] [Abstract][Full Text] [Related]
14. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
Marín-Hernández A; Gallardo-Pérez JC; Ralph SJ; Rodríguez-Enríquez S; Moreno-Sánchez R
Mini Rev Med Chem; 2009 Aug; 9(9):1084-101. PubMed ID: 19689405
[TBL] [Abstract][Full Text] [Related]
15. Lactate shuttle: from substance exchange to regulatory mechanism.
Wang X; Liu H; Ni Y; Shen P; Han X
Hum Cell; 2022 Jan; 35(1):1-14. PubMed ID: 34606041
[TBL] [Abstract][Full Text] [Related]
16. Natural products as glycolytic inhibitors for cervical cancer treatment: A comprehensive review.
Liu Q; Chen X; Tan Y; Liu J; Zhu M; Li D; Zhou Y; Zhang T; Yin QZ
Biomed Pharmacother; 2024 Jun; 175():116708. PubMed ID: 38723515
[TBL] [Abstract][Full Text] [Related]
17. Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review.
Fakhri S; Moradi SZ; Farzaei MH; Bishayee A
Semin Cancer Biol; 2022 May; 80():276-305. PubMed ID: 32081639
[TBL] [Abstract][Full Text] [Related]
18. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents.
Hashem S; Ali TA; Akhtar S; Nisar S; Sageena G; Ali S; Al-Mannai S; Therachiyil L; Mir R; Elfaki I; Mir MM; Jamal F; Masoodi T; Uddin S; Singh M; Haris M; Macha M; Bhat AA
Biomed Pharmacother; 2022 Jun; 150():113054. PubMed ID: 35658225
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]